News |

Shore Capital has this morning been appointed as Joint Broker to Echo Energy Plc (AIM: ECHO)

  Appointment of Joint Corporate Broker Echo Energy, the South and Central American focused upstream gas company, is pleased to […]

 

News |

Shore Capital acted as Nominated Adviser and Sole Bookrunner on the AIM IPO of Cake Box Holdings plc

      We are pleased to announce that Shore Capital has successfully raised c.£16.5m in connection with the AIM IPO […]

 

News |

European Mediscience Awards Dinner 2018

    Shore Capital was delighted to honour Dr. Werner Lanthaler, CEO of Evotec, at the European Mediscience Awards 2018 […]

 

News |

Shore Capital acts as Joint Bookrunner on the placing for Playtech plc

    Shore Capital is delighted to have acted as joint bookrunner for Playtech plc, on the placing of its […]

 

SCGL Performance of Funds – April 2018

The following table gives the performance for the month ended 30 April 2018 of the funds managed by the Group’s […]

 

News |

Shore Capital acts as Joint Bookrunner on the placing by Dairy Crest Group Plc

    Shore Capital is delighted to have acted on the placing by Dairy Crest Group Plc to raise £70 […]

 

News |

Shore Capital Technology Conference – Session Highlights

On the morning of Tuesday, the 15th of May Shore Capital hosted its technology conference focussed on digital technology and […]

 

News |

Shore Capital acts as Sole Bookrunner: Oversubscribed Placing to Raise £5.5m for Ixico Plc

IXICO plc (“IXICO” or the “Company”)   IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, is pleased to […]

 

SCGL Performance of Funds – March 2018

The following table gives the performance for the month ended 31 March 2018 of the funds managed by the Group’s […]

 

News |

Shore Capital appointed to provide Corporate Access and Research Services to Savannah Petroleum plc

Shore Capital is pleased to have been appointed to provide Corporate Access and Research Services to Savannah Petroleum (AIM: SVAP). […]

 

News |

Big pharma model is being challenged

Shore Capital Healthcare Analyst, Tara Raveendran, discusses how innovation, coming from small and mid-cap companies, is challenging big pharma on […]

 

News |

Life Science Analysis: What does Roche’s takeover of Flatiron Health mean?

With Roche being particularly active on the real-world-data front with its recent acquisition of the US cancer data analytics firm […]

 

News |

Technology Conference

  The Technology Conference is being organised by Shore Capital Stockbrokers Limited. We have considered that the event, based on […]

 

News |

Shore Capital Appointed Joint Broker to Sirius Minerals Plc

    Shore Capital is pleased to have been appointed as joint broker to Sirius Minerals Plc (Premium: SXX). Sirius […]

 

SCGL Director/PDMR Shareholding

Shore Capital Group Limited (“Shore Capital” or the “Company”) Director/PDMR Shareholding Shore Capital was notified today that David Kaye, a […]

 

SCGL Director/PDMR Shareholding

Shore Capital Group Limited (“Shore Capital” or the “Company”) Director/PDMR Shareholding Shore Capital was notified today that David Kaye, a […]

 

News |

Shore Capital’s Kevin MacDonald wins the Mudlark Award for Exceptional Performance in the Back Office

We’re delighted to announce that Kevin MacDonald, Head of Operations at Shore Capital, has won the Mudlark Award for ‘Exceptional […]

 

SCGL Performance of Funds – February 2018

The following table gives the performance for the month ended 28 February 2018 of the funds managed by the Group’s […]

 

News |

Preliminary Results for the Year Ended 31 December 2017

Strong Group performance with significant growth in revenues and profitability Shore Capital, the independent investment group specialising in capital markets, […]

 

News |

Shore Capital acts as Sole Bookrunner: Successful Completion of Placing to Raise £12m for Yu Group

   Yü Group PLC (the “Group” or “Company”)   Successful completion of placing to raise £12.0 million  Yü Group PLC […]